Data - Pivotal Clinical Evidence Supporting European Centralised Approvals of New Active Substances between 2023 and 2024

Data use for the study titled "Pivotal Clinical Evidence Supporting European Centralised Approvals of New Active Substances between 2023 and 2024" Data consists of 3 datasheets (.csv) PivotalEvidence_cleanData_Sample.csv, PivotalEvidence_cleanData_ApprovedIndications.csv and PivotalEvidence_cleanData_PivotalTrials.csv. Data can be linked using the variable EMA.product.number and Indication.MeSH. In the ReadMe.csv there is a short description of all variables in the three data sheets. All data was collected in July/August 2025, and include all New Active substances approve by through the Europena union Centralised procedure.